Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

Investment Tag

Excellerate Bioscience is delighted that a close relationship with Omass Therapeutics, built over 18 months, has helped contribute to their success in securing extended series A funding. During this period, Excellerate assembled a dedicated team of expert pharmacologists focussed exclusively on driving forward the Omass...

Amphista’s potent bifunctional small molecules augment targeted protein degradation Investors include Advent Life Sciences, the Scottish Investment Bank, the European Investment Fund and US-based BioMotiv   Glasgow, Scotland, 7 April 2020 – Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes...

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) has significantly increased its tablet manufacturing capabilities following a strategic investment in a new state-of the-art tablet press. This investment will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support...

Cheshire UK, 29 August 2019 BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is an...

BioCity, the pioneering life science and business collective has announced co-investment into Rinri Therapeutics. A biotechnology company developing a novel cell-based therapy to restore hearing, Rinri Therapeutics have successfully secured £1.4 million in seed funding. BioCity’s recent investment in the biotech company, marks the 28th investment...

Nottingham, UK – 02 May 2019   BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...